McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other …
Over the last 12 months, insiders at McKesson Corporation have bought $0 and sold $26.67M worth of McKesson Corporation stock.
On average, over the past 5 years, insiders at McKesson Corporation have bought $0 and sold $40.94M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 1,384 shares for transaction amount of $200,013 was made by Schechter Lori A. (EVP, GC & Chief Compl. Officer) on 2016‑11‑30.
2024-09-05 | Sale | Chief Executive Officer | 3,753 0.0032% | $561.10 | $2.11M | -1.17% | ||
2024-08-05 | Sale | Chief Executive Officer | 3,753 0.003% | $626.03 | $2.35M | -16.02% | ||
2024-07-03 | Sale | Chief Executive Officer | 3,753 0.0028% | $580.92 | $2.18M | 0.00% | ||
2024-06-11 | Sale | EVP & Chief HR Officer | 600 0.0005% | $585.53 | $351,318 | -6.98% | ||
2024-06-07 | Sale | director | 483 0.0004% | $585.88 | $282,979 | -6.14% | ||
2024-06-05 | Sale | Chief Executive Officer | 3,753 0.0029% | $574.41 | $2.16M | -4.84% | ||
2024-05-31 | Sale | EVP, Chief Strategy & BDO | 5,232 0.004% | $560.99 | $2.94M | -2.48% | ||
2024-05-29 | Sale | EVP & CFO | 2,427 0.0018% | $550.00 | $1.33M | -0.40% | ||
2024-05-29 | Sale | EVP, Chief Strategy & BDO | 133 0.0001% | $550.00 | $73,150 | -0.40% | ||
2024-05-29 | Sale | EVP & Chief HR Officer | 202 0.0002% | $550.00 | $111,100 | -0.40% | ||
2024-05-28 | Sale | EVP & CFO | 894 0.0007% | $557.40 | $498,316 | +1.49% | ||
2024-05-28 | Sale | EVP, Chief Strategy & BDO | 789 0.0006% | $557.40 | $439,789 | +1.49% | ||
2024-05-28 | Sale | EVP & Chief HR Officer | 206 0.0002% | $557.40 | $114,824 | +1.49% | ||
2024-05-23 | Sale | EVP & CFO | 12,752 0.0098% | $558.09 | $7.12M | -0.10% | ||
2024-05-23 | Sale | EVP & Chief HR Officer | 704 0.0005% | $558.09 | $392,895 | -0.10% | ||
2024-05-13 | Sale | director | 0.98 <0.0001% | $554.61 | $541 | +0.45% | ||
2024-05-10 | Sale | director | 610 0.0005% | $558.04 | $340,403 | -0.58% | ||
2024-03-15 | Sale | Chief Executive Officer | 3,473 0.0026% | $524.55 | $1.82M | +1.84% | ||
2024-03-04 | Sale | SVP, Controller & CAO | 190 0.0001% | $529.99 | $100,698 | +0.95% | ||
2024-02-13 | Sale | EVP & Chief HR Officer | 186 0.0001% | $496.00 | $92,256 | +6.14% |
SALKA SUSAN R | director | 0 0% | $626.78 | 2 | 2 | +8.02% |
Schechter Lori A. | EVP, Chief Legal Officer & GC | 186 0.0001% | $626.78 | 1 | 29 | +3.29% |
Jacobs Christine M | director | 0 0% | $626.78 | 1 | 13 | +6.19% |
The Vanguard Group | $6.46B | 9.28 | 12.04M | -0.86% | -$56.01M | 0.12 | |
BlackRock | $6.13B | 8.81 | 11.42M | -2.09% | -$130.69M | 0.13 | |
State Street | $3.35B | 4.81 | 6.24M | -1.21% | -$41.12M | 0.14 | |
Massachusetts Financial Services Co Ma | $2.64B | 3.79 | 4.91M | -2.24% | -$60.41M | 0.79 | |
JPMorgan Chase | $2.34B | 3.36 | 4.36M | +0.5% | +$11.63M | 0.21 |